The End Gas Station Heroin Act adds two specific kratom compounds, 7-hydroxymitragynine and mitragynine pseudoindoxyl, to the federal list of Schedule I controlled substances. However, it includes an exemption for these compounds when they occur naturally in finished kratom products that meet strict concentration limits, while explicitly excluding synthetically produced or chemically concentrated versions from this protection. The bill also creates a new enforcement mechanism that treats any emerging synthetic opioid with greater potency than morphine as a Schedule I controlled substance if it is manufactured or distributed for commercial sale. This provision targets the production and distribution of these substances but explicitly prohibits criminal or civil penalties for simple possession or personal use by consumers.
The End Gas Station Heroin Act amends the Controlled Substances Act to place 7-hydroxymitragynine and mitragynine pseudoindoxyl in Schedule I, while exempting naturally occurring kratom products that meet specific low-concentration limits. The bill also creates a new enforcement mechanism for emerging synthetic opioids by treating them as Schedule I controlled substances when they are manufactured or distributed commercially. This provision applies to synthetic opioids that are more potent than morphine and not approved for medical use, but it explicitly prohibits criminal or civil penalties for simple possession or personal use.
Pennsylvania Senate Bill 1425 establishes a five-year pilot program in Philadelphia that requires law enforcement to directly notify all registered motor vehicle repair facilities when a hit-and-run accident results in serious injury or death. The bill mandates that commercial garages and shops register with the city to receive these alerts, which include specific details such as the vehicle's make, model, color, license plate number, and extent of damage. If a repair facility discovers a vehicle in its possession that matches the description in an alert, the owner or operator must report it to law enforcement within 72 hours. Failure to comply with this reporting requirement is punishable by a third-degree misdemeanor, and the city must submit annual reports to state agencies detailing the program's costs and activity.
Pennsylvania House Bill 2747 amends the state's Controlled Substance, Drug, Device and Cosmetic Act to add eight specific synthetic benzimidazole-opioid substances, commonly known as nitazenes, to Schedule I of controlled drugs. These substances are classified as having a high potential for abuse with no currently accepted medical use in the United States. The bill directly affects individuals who manufacture, sell, or possess these specific chemicals by subjecting them to the strict penalties and regulations associated with Schedule I drugs. The new provisions take effect 60 days after the act is signed into law.
New York State Penal Law would add a new offense, "criminal sale of a controlled substance resulting in death," making it a class A-1 felony. The crime applies when a person sells, exchanges, gives, disposes of, or supplies any scheduled controlled substance (Schedules I-V) to another person and that person's use of the drug causes their death. The bill takes effect 30 days after enactment and authorizes immediate rulemaking needed for implementation.
Report of the Cape and Islands District Attorney (pursuant of Section 47(d) of Chapter 94C of the General Laws) submitting its 2026 report relative to the use of monies in the law enforcement trust fund for the purposes of drug rehabilitation, drug education, and other anti-drug or neighborhood crime watch programs
The Insider Trading Prohibition Act creates a new federal criminal statute that makes it illegal to buy or sell securities while knowingly in possession of material, nonpublic information that was obtained wrongfully. The bill defines wrongful conduct to include actions such as theft, breach of fiduciary duty, or unauthorized access to data, and explicitly covers situations where an individual consciously avoids knowing the details of how the information was acquired. It also prohibits sharing this type of sensitive information if the sender knows it will be used for trading. While the law allows for certain exemptions, including transactions made under pre-existing Rule 10b5-1 plans, it ensures that these new penalties apply in addition to existing legal remedies.
The Cannabis Administration and Opportunity Act fundamentally changes federal law by removing marijuana from the Controlled Substances Act, effectively decriminalizing it at the federal level and allowing states to regulate their own cannabis markets without federal interference. To manage this new landscape, the bill creates a new federal agency called the Alcohol, Tobacco, and Cannabis Tax and Trade Bureau to oversee licensing, collect taxes, and prevent illicit trade, while also establishing a new Center for Cannabis Products within the FDA to regulate safety and labeling. The legislation includes significant restorative justice measures, such as automatically expunging federal cannabis convictions and prohibiting discrimination against individuals with such records in areas like immigration, security clearances, and access to federal benefits. Additionally, the bill provides billions of dollars in funding to support research into the health effects of cannabis, expand access to financial services for legitimate cannabis businesses, and assist communities and individuals harmed by past prohibition enforcement.
This bill, known as the Deputy Darren Almendarez Act, adds a new federal crime for knowingly possessing or purchasing catalytic converters removed from vehicles with the intent to sell or distribute them. It directly affects individuals involved in the removal and resale of these parts, as well as businesses like scrap yards and repair shops, by establishing penalties of up to five years in prison and fines of $100,000 for first offenses. The law includes specific exceptions that allow for legal possession or purchase if the converter was removed by a vehicle owner, acquired during official duties by authorized entities, or bought from licensed businesses that follow state and local identification rules. For repeat offenders, the potential prison sentence increases to ten years and the fine limit rises to $200,000.
This bill, known as the No Leniency for Fentanyl Dealers Act, aims to increase penalties for trafficking fentanyl and other synthetic opioids while enhancing detection efforts by the U.S. Postal Service. It lowers the quantity thresholds required for federal felony charges and mandates that sentencing guidelines be updated to reflect these stricter penalties. Additionally, the legislation directs the Postmaster General to purchase more chemical screening devices and hire scientists to identify illegal drugs in mail shipments, authorizing $9 million in funding to support these interdiction activities.
